Ozempic – Type 2 Diabetes – Novo Ozempic GM APR Display Banners HCP Wallboard Extension 2023 – 53875

Most US adults with T2D meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10% use either, according to a research...

The risk for diabetes is increased after COVID-19 infection, even during the phase dominated by Omicron variants, according to a research letter published in JAMA Network Open. Alan C. Kwan, MD, and colleagues examined whether...

Announcements from the AMA and the AAP, plus innovative drug launches, are some of the major developments in Obesity Medicine. The year has opened with many important new milestones in obesity medicine. Healthcare professionals...

Certain phthalate metabolites are associated with an increased incidence of diabetes in women, especially among White women, according to a study published in the Journal of Clinical Endocrinology & Metabolism. Mia Q. Peng,...

For patients with diabetes mellitus (DM), pioglitazone use is associated with a reduced risk for dementia, especially in those with a history of ischemic heart disease or stroke, according to a study published in Neurology....

“Sulfonylureas and β-blockers are commonly used together among patients with T2D and arterial hypertension or cardiovascular disease,” explains Antonios Douros, MD. “While both medication classes are known to increase the risk...